Annual Cash & Cash Equivalents
$200.02 M
+$42.72 M+27.16%
December 31, 2023
Summary
- As of February 8, 2025, XBIT annual cash & cash equivalents is $200.02 million, with the most recent change of +$42.72 million (+27.16%) on December 31, 2023.
- During the last 3 years, XBIT annual cash & cash equivalents has fallen by -$37.34 million (-15.73%).
- XBIT annual cash & cash equivalents is now -72.01% below its all-time high of $714.59 million, reached on December 31, 2019.
Performance
XBIT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$183.12 M
-$5.41 M-2.87%
September 30, 2024
Summary
- As of February 8, 2025, XBIT quarterly cash and cash equivalents is $183.12 million, with the most recent change of -$5.41 million (-2.87%) on September 30, 2024.
- Over the past year, XBIT quarterly cash and cash equivalents has dropped by -$19.07 million (-9.43%).
- XBIT quarterly cash and cash equivalents is now -74.37% below its all-time high of $714.59 million, reached on December 31, 2019.
Performance
XBIT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XBIT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.2% | -9.4% |
| 3 y3 years | -15.7% | -23.3% |
| 5 y5 years | +1164.1% | +354.0% |
XBIT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.6% | +27.2% | -22.7% | +27.7% |
| 5 y | 5-year | -72.0% | +27.2% | -74.4% | +27.7% |
| alltime | all time | -72.0% | +4700.2% | -74.4% | +2427.9% |
XBiotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $183.12 M(-2.9%) |
| Jun 2024 | - | $188.53 M(-6.2%) |
| Mar 2024 | - | $201.04 M(+0.5%) |
| Dec 2023 | $200.02 M(+27.2%) | $200.02 M(-1.1%) |
| Sep 2023 | - | $202.19 M(+41.0%) |
| Jun 2023 | - | $143.39 M(-6.0%) |
| Mar 2023 | - | $152.48 M(-3.1%) |
| Dec 2022 | $157.31 M(-33.6%) | $157.31 M(-2.0%) |
| Sep 2022 | - | $160.57 M(-28.9%) |
| Jun 2022 | - | $225.79 M(-2.6%) |
| Mar 2022 | - | $231.82 M(-2.2%) |
| Dec 2021 | $236.98 M(-0.2%) | $236.98 M(-0.8%) |
| Sep 2021 | - | $238.88 M(-24.2%) |
| Jun 2021 | - | $315.26 M(+31.4%) |
| Mar 2021 | - | $239.88 M(+1.1%) |
| Dec 2020 | $237.37 M(-66.8%) | $237.37 M(-0.4%) |
| Sep 2020 | - | $238.43 M(+3.8%) |
| Jun 2020 | - | $229.70 M(-4.9%) |
| Mar 2020 | - | $241.54 M(-66.2%) |
| Dec 2019 | $714.59 M | $714.59 M(+1671.5%) |
| Sep 2019 | - | $40.34 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $44.92 M(+273.7%) |
| Mar 2019 | - | $12.02 M(-24.0%) |
| Dec 2018 | $15.82 M(-50.2%) | $15.82 M(-24.1%) |
| Sep 2018 | - | $20.85 M(-16.1%) |
| Jun 2018 | - | $24.85 M(-12.6%) |
| Mar 2018 | - | $28.42 M(-10.6%) |
| Dec 2017 | $31.77 M(-7.4%) | $31.77 M(-18.5%) |
| Sep 2017 | - | $38.98 M(-15.2%) |
| Jun 2017 | - | $45.95 M(-15.9%) |
| Mar 2017 | - | $54.63 M(+59.2%) |
| Dec 2016 | $34.32 M(-62.3%) | $34.32 M(-26.6%) |
| Sep 2016 | - | $46.79 M(-27.8%) |
| Jun 2016 | - | $64.80 M(-17.2%) |
| Mar 2016 | - | $78.22 M(-14.1%) |
| Dec 2015 | $91.05 M(+58.8%) | $91.05 M(-13.8%) |
| Sep 2015 | - | $105.68 M(-10.0%) |
| Jun 2015 | - | $117.38 M(+124.7%) |
| Mar 2015 | - | $52.24 M(-8.9%) |
| Dec 2014 | $57.33 M(+691.4%) | $57.33 M(+269.9%) |
| Sep 2014 | - | $15.50 M(+113.9%) |
| Dec 2013 | $7.24 M(+73.8%) | $7.24 M |
| Dec 2012 | $4.17 M | - |
FAQ
- What is XBiotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for XBiotech?
- What is XBiotech annual cash & cash equivalents year-on-year change?
- What is XBiotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for XBiotech?
- What is XBiotech quarterly cash and cash equivalents year-on-year change?
What is XBiotech annual cash & cash equivalents?
The current annual cash & cash equivalents of XBIT is $200.02 M
What is the all time high annual cash & cash equivalents for XBiotech?
XBiotech all-time high annual cash & cash equivalents is $714.59 M
What is XBiotech annual cash & cash equivalents year-on-year change?
Over the past year, XBIT annual cash & cash equivalents has changed by +$42.72 M (+27.16%)
What is XBiotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XBIT is $183.12 M
What is the all time high quarterly cash and cash equivalents for XBiotech?
XBiotech all-time high quarterly cash and cash equivalents is $714.59 M
What is XBiotech quarterly cash and cash equivalents year-on-year change?
Over the past year, XBIT quarterly cash and cash equivalents has changed by -$19.07 M (-9.43%)